Pharmacovigilance – News and Features

News
Study Shows that Geron’s Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack By The Human Immune System
Data indicate short courses of low-dose immunosuppression may be sufficient to prevent immune rejection of GRNOPC1.

News
Drug Commonly Used to Treat Bi-Polar Disorder Dramatically Increases Lifespan in Nematode Worms
Scientists at Buck Institute discovered that longevity was increased in the worms when the lithium turned down the activity of a gene that modulates the basic structure of chromosomes.

News
NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Pharmaceutical Company
As part of the feasibility agreement, NMT will apply its proprietary technology High Gravity Controlled Precipitation to the design of drug particles for pulmonary inhalation.

News
How Schizophrenia Develops: Major Clues Discovered
Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain.

News
Genes that Affect Reponses of MS to Copaxone
A group of Israeli scientists have recently identified genes responsible for the positive response of many multiple sclerosis patients to the drug Copaxone®.

News
Study Reveals how Stem Cells Decide to Become either Skeletal or Smooth Muscle
The study results provide insight into the development biology and suggest new ways to treat atherosclerosis and cancer.

News
Montreal Heart Institute Awarded $5 Million Grant from Genome Quebec
MHI’s research project based on a mixed academic/private partnership in pharmacogenomics has been selected for the new PRIVAC competition launched by Genome Quebec.

News
Report Urges Genomic Methods to Identify Toxic Chemicals Should be Developed
A report from National Research Council recommends development of genomic technologies for identifying toxic chemicals and understanding individual vulnerabilities.

News
Aastrom Announces Positive Interim Results from Phase I/II Study Involving use of Vascular Repair Cells in Patients with Critical Limb Ischemia
Early clinical data supporting use of Aastrom Bone Repair Cells (BRCs) in treatment of osteonecrosis of the femoral head also presented.

News
International Serious Adverse Events Consortium Launches Global Research Collaboration to Identify Genetic Markers Related to Adverse Drug Reactions
Newly formed nonprofit corporation unites industry, academia and government in first large-scale study of genetics and drug safety.
Advertisement